Ozurdex in the treatment of macular edema caused by posterior ophthalmic diseases

doi:10.3760/ cma.j.issn.1673-5803.2020.05.009

International Review of Ophthalmology ›› 2020, Vol. 44 ›› Issue (5): 346-350.doi: 10.3760/ cma.j.issn.1673-5803.2020.05.009

Previous Articles Next Articles

Ozurdex in the treatment of macular edema caused by posterior ophthalmic diseases

Tan Cong, Qin Mei

Department of Ophthalmology, the First Affiliated Hospital of Bengbu Medical College, Bengbu Anhui 233000, China

Received:2020-04-07 Online:2020-10-22 Published:2020-11-01
Contact: Qin Mei, Email: bbmcqm@163.com

Abstract

Abstract:

Macular edema is one of the main causes of visual dysfunction in patients with fundus disease. Many factors cause the destruction of blood-retinal barrier and form macular edema, among which inflammation plays an important role in the formation of macular edema. In order to overcome the limitations of traditional intravitreous hormone injection, dexamethasone vitreous implant (Ozurdex) came into being. Its good clinical effect and unique drug delivery system provide a new choice for the treatment of macular edema. Ozurdex has good efficacy and safety in the theatment of macular edema caused by fundus diseases such as retinal vein occlusion, diabetic retinopathy and non-infective uveitis.(Int Rev Ophthalmol, 2020, 44：346-350)

Key words: Ozurdex, macular edema, retinal vein occlusion, diabetic macular edema, noninfectious uveitis

Tan Cong, Qin Mei. Ozurdex in the treatment of macular edema caused by posterior ophthalmic diseases[J]. International Review of Ophthalmology, 2020, 44(5): 346-350.

[1]	Huang Ju, Li Shiyi, Zhang Ao, Wang Kang, Xie Yingbin. Research progress on anti-VEGF drugs and glucocorticaid drugs for the treatment of retinal vein occlusion-associated macular edema [J]. International Review of Ophthalmology, 2024, 48(4): 267-272.
[2]	Hu Yizhuo, Zhang Fengyan. Research advance of peudophakic cystoid macular edema [J]. International Review of Ophthalmology, 2024, 48(3): 210-216.
[3]	. Research progress of laser-induced chorioretinal venous anastomosis in the treatment of non-ischemic central retinal vein occlusion [J]. International Review of Ophthalmology, 2024, 48(2): 129-132.
[4]	Pang Shaofang, Yang Meng, Hu Bojie. Biomarkers for the treatment effect of diabetic macular edema with anti-vascular endothelial growth factors [J]. International Review of Ophthalmology, 2023, 47(2): 144-149.
[5]	Zhu Yingxing, Zou Yue, Feng Xiaoxiao, Hua Qiyun, Xiao Libo, Li Yunqin, . Research progress of aflibercept in the treatment of diabetic macular edema [J]. International Review of Ophthalmology, 2023, 47(1): 74-78.
[6]	Qin Haifeng, Xu Guoxu, Zhang Jingfa. Roles of hypoxia and inflammation in the pathogenesis of macular edema secondary to retinal vein occlusion [J]. International Review of Ophthalmology, 2022, 46(2): 173-178.
[7]	Yin Lidong, Jiang Bo, Zhang Zhongyu, Sun Dawei. T&E regimen for diabetic macular edema [J]. International Review of Ophthalmology, 2021, 45(6): 477-482.
[8]	Wei Puying, Zhang Wenbo, Yang Liu. Application of microperimetry in macular edema [J]. International Review of Ophthalmology, 2021, 45(3): 216-220.
[9]	Linghu Minli, Huang Xionggao. Application of OCTA on diagnosis and treatment of retinal vascular diseases [J]. International Review of Ophthalmology, 2020, 44(5): 351-357.
[10]	Yang Su, Sun Dawei. Systemic related factors of diabetic macular edema [J]. International Review of Ophthalmology, 2020, 44(1): 57-62.
[11]	Wang Beibei, Li Qiuming, Dong Shuqian, Hu Zhirou. Treatment of macular edema after vitrectomy [J]. International Review of Ophthalmology, 2019, 43(6): 366-372.
[12]	Zhou Jinqiong, Zhou Haiying. Subthreshold micropulse laser photocoagulation for diabetic macular edema [J]. International Review of Ophthalmology, 2019, 43(3): 170-175.
[13]	Liao Dan, Li Linrui, Yang Xiaoli. Application of subthreshold micropulse laser on treatment of macular disorders [J]. International Review of Ophthalmology, 2019, 43(1): 58-61.
[14]	HUANG Yin-hua, YE Bo. The relationship between diabetic macular edema and inflammation [J]. International Review of Ophthalmology, 2017, 41(1): 62-67.
[15]	ZHANG Zhi-chun, WANG Hao.. Research progress of anti-vascular endothelial growth factor for macular edema secondary to retinal vein occlusion [J]. International Review of Ophthalmology, 2016, 40(5): 289-294.

Ozurdex in the treatment of macular edema caused by posterior ophthalmic diseases

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments